Trials / Unknown
UnknownNCT02076516
Pilot Evaluation Of CORACTO® (THE PILOT-SECRET TRIAL)
Pilot Evaluation Of CORACTO® (Rapamycin-Eluting Coronary Stent Delivery System) in The Treatment Of Patients With Coronary Artery Disease
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Alvimedica · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of the CORACTO® (Rapamycin®-Eluting coronary stent delivery system) for the treatment of up to two de novo lesions or restenotic post-PTCA (non-stented) lesions located in up to two epicardial native coronary arteries (maximum one lesion per vessel) suitable for treatment with stents from 2.5 to 4.0 mm in diameter \< than 15 mm suitable for treatment with a single CORACTO® stent in a population of 100 patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Drug-eluting stent: CORACTO® |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-10-01
- Completion
- 2015-05-01
- First posted
- 2014-03-03
- Last updated
- 2014-03-03
Locations
5 sites across 4 countries: Belgium, France, Spain, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02076516. Inclusion in this directory is not an endorsement.